Updated:
Clinical Ink
Explore Clinical ink's comprehensive eSource platform and clinical trial solutions. We drive data quality and operational excellence in clinical research.
Clinical Ink
Explore Clinical ink's comprehensive eSource platform and clinical trial solutions. We drive data quality and operational excellence in clinical research.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Winston-Salem
Corporate office
119 Brookstown Ave, Ste 101, Winston-Salem, NC 27101, United States
Additional offices
Horsham, PA
Principals
Christian Born Djurhuus
Chief Science Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Clinical Ink?
Clinical Ink's leadership is not publicly named beyond the appointment of Dr. Christian Born Djurhuus as Chief Science Officer (per the firm's website, 2025). The firm does not disclose its board or executive team on its site.
How does Clinical Ink source proprietary deal flow?
Clinical Ink is a technology company, not an investment firm. It sources business through direct sales to sponsors and CROs, and its pipeline is driven by the need for decentralized clinical trial technology (per the firm's website).
Is Clinical Ink structured as a single family office or does it operate more like a venture firm?
Clinical Ink operates as a commercial technology company providing eSource clinical trial software. Its ownership structure is not publicly disclosed; there is no evidence it functions as a family office or investment vehicle.
Does Clinical Ink participate in fund commitments or only direct deals?
Clinical Ink is a product company that sells eSource platforms and services to sponsors and CROs. It does not make fund commitments or direct investments.
What therapeutic areas does Clinical Ink support?
Clinical Ink focuses on neurology, infectious disease, immunology (including lupus), oncology, and diabetes (per the firm's website). Its tools are designed for complex therapies requiring decentralized data collection.
Does Clinical Ink maintain philanthropic structures, and how are they separated?
Clinical Ink does not publicly disclose any philanthropic structures or foundations. Its activities are strictly commercial.
What is Clinical Ink's known posture on co-investments alongside external GPs?
Clinical Ink is not an investment firm and does not participate in co-investments alongside external GPs.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: